Dr. Bressler is a Clinical Assistant Professor of Medicine, in the Division of Gastroenterology at the University of British Columbia’s Department of Medicine. Dr. Bressler received his MD from the University of British Columbia and completed his residency in internal medicine and gastroenterology at the University of Toronto. He received an MS in Epidemiology from the Harvard Public School of Health and completed an advanced fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School. Dr. Bressler is a recognized expert in inflammatory bowel disease. His research interests include population based studies, classic clinical epidemiology studies and clinical trials in inflammatory bowel disease. He is an invited reviewer for many medical journals including Gastroenterology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology.
A recipient of numerous awards, research fellowships and grants, Dr. Richard N. Fedorak is an internationally recognised expert in inflammatory bowel disease. He has an active basic gastrointestinal research laboratory in the area of mucosal immunology, inflammation, and membrane function and structure and leads a large gastrointestinal disease clinical research group. Dr. Fedorak serves on multiple national and international scientific advisory boards. He has published over 500 peer-reviewed manuscripts and book chapters, produced two patents on colonic-specific drug delivery, and has lectured around the world. He has multiple grant review committee memberships and editorial positions with front ranked gastrointestinal journals. Currently, Dr. Fedorak is Associate Vice President (Research) and Professor of Medicine in the Division of Gastroenterology at the University of Alberta and also serves as Director for both the Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) and the Northern Alberta Clinical Trials and Research Centre (NACTRC). In addition, Dr. Fedorak is President of the Canadian Digestive Health Foundation (CDHF) and Chairman of the Research Committee, World Gastroenterology Organization. Dr. Fedorak received his medical degree with First Class Honours from the University of Alberta. His Gastroenterology Clinical and Research Fellowship training was carried out at the University of Chicago and Columbia University, New York.
Dr. Panaccione is currently a Professor of Medicine at the University of Calgary and the Director of the Inflammatory Bowel Disease Clinic at the University of Calgary as well as Director of Gastroenterology Research for the Division of Gastroenterology and Hepatology. He is a recognized international expert in the diagnosis, management, and treatment of inflammatory bowel disease. Dr. Panaccione sits on many editorial boards and serves as a reviewer for the New England Journal of Medicine, Gastroenterology, Gut, APT, and Inflammatory Bowel Diseases. He has lectured across North America on various topics in inflammatory bowel disease and has delivered over 175 lectures in the last five years. He has been elected to the International Organization of IBD (IOIBD) and has received the highest award, the Finklestein award for this contribution to the field of IBD by Crohn’s and Colitis Canada. Dr. Panaccione graduated from the University of Western Ontario (London, Ontario) with a degree in Medicine in 1993. He went on to complete his Internal Medicine and Gastroenterology training at the University of Western Ontario. Dr. Panaccione completed advanced training in Inflammatory Bowel Disease at the Mayo Clinic in Rochester, Minnesota. He joined the faculty of Medicine at the University of Calgary in 1999.
Dr. Marshall is an Associate Professor of Medicine at McMaster University and an active consultant gastroenterologist at Hamilton Health Sciences. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. There he is now a Full Member of the Farncombe Family Digestive Health Research Institute, Director of the Training Program in Adult Gastroenterology, and Head of Clinical Research for the Division of Gastroenterology.
His publications include over 90 academic papers and book chapters and 100 abstracts. He serves as an Associate Editor of the ACP Journal Club and Evidence-Based Medicine, Co-Editor of the Cochrane Collaboration IBD Review Group and a Member of Editorial Boards for the Canadian Journal of Gastroenterology and the World Journal of Gastroenterology.
Dr. Marshall has held a Clinician Scientist Award from the Canadian Institutes of Health Research (CIHR) and has received peer-reviewed research funding from several agencies including CIHR and the Crohn’s and Colitis Foundation of Canada. Recent honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), Fellowship in the American Gastroenterological Association (2007), the CAG Young Educator Award (2006) and the American College of Gastroenterology Governor’s Award for Excellence in Clinical Research (2003).
Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, clinical trials, clinical epidemiology, health outcomes and health economics.
Dr. Axler has practiced community Gastroenterology in Toronto since 1984. He is well known in Ontario as a leader in the practice and research of GI disorders, particularly in IBD. A graduate of the University of Toronto GI program, he is a Lecturer in Gastroenterology at the University of Toronto, and teaches GI Fellows and Residents about managing IBD and GI clinical research in the community setting. He has been a clinical researcher and an executive member of Toronto Digestive Disease Associates for the past 15 years. He has participated in over 110 clinical trials and been the Principal Investigator for over 20 clinical trials. He has co-authored articles including NEJM (2013) on new emerging biologics. He has been the Section Head of GI in the Ontario Medical Association and has served as President of the Ontario Association of Gastroenterology, and continues on their board. He was appointed as a reviewer of Out of Hospital Endoscopy clinics and as a Peer Assessor by the College of Physicians and Surgeons of Ontario. He continues to practice community Gastroenterology in Toronto, and is active in many clinical research studies. He was the head of GI and Endoscopy at Etobicoke General Hospital for 25 years. He is also the head of GI and Endoscopy at the Medcan Clinic in down town Toronto.
Dr. Sutcliffe is the Chief Medical Officer (CMO) at Qu Biologics Inc. He is a distinguished clinician, scientist and leading visionary in cancer control in Canada and internationally. A graduate of St. Bartholomew’s Hospital, London, England, Dr. Sutcliffe’s training encompassed internal medicine, scientific research, medical and radiation oncology in the UK, South Africa, US and Canada. Dr. Sutcliffe has been President and CEO of the Ontario Cancer Institute and Princess Margaret Hospital (1994-96) and the BC Cancer Agency (2000-09). Dr. Sutcliffe is currently the President of the International Cancer Control Congress Association, President of Two Worlds Cancer Collaboration (the Canadian Branch of the International Network for Cancer Treatment and Research), and Board Chair, Institute for Health Systems Sustainability. Dr. Sutcliffe was awarded the Queen Elizabeth 50th Jubilee Gold Medal in 2003 and the Terry Fox Award (of the B.C. Medical Association) in 2009 for his lifetime services to cancer control.
Dr. Zarowny is acting as an independent Medical Monitor for the Qu Crohn’s Trial. He has extensive expertise in the ethical conduct of clinical trials to ensure that participant safety is a top priority. With a Master of Science degree and a Doctorate of Medicine from the University of Manitoba, Dr. Zarowny started his career in family practice prior to moving to the pharmaceutical industry where he held positions such as Director of Clinical Pharmacology, Vice-President and Medical Director and Director of Medical and Scientific Affairs, in Canada, for international companies such as Hoffmann-La Roche. Dr. Zarowny then joined the Canadian HIV Trials Network (CTN) as Programme Head, Scientific and Industrial Liaison (1990-2008). He has been Senior Chair of the U-I grants review committee of Canadian Institutes of Health Research (CIHR), and the founding chair of the Canadian Panel of the Western Institutional Review Board (WIRB®). Dr. Zarowny has published over 50 scientific papers and given over 30 invited scientific presentations. Currently he acts as consultant to biotechnology companies, sits on the Jury of the Prix Galien, is a member of Panel 10 of WIRB®, and a member of WIRB®’s Institutional BioSafety Committee.